tirzepatide side effects heart palpitations Should a patient with tachycardia stop taking (glucagon-like peptide-1 (GLP-1) receptor agonist)? 🤔Ever felt your heart suddenly

Research suggests these treatments may work synergistically in specific populations, though clinical decision-making requires careful assessment of individual health status, hormone levels, and metabolic goals

The proportion of patients achieving at least a 4.3-point increase from baseline in physical function, semaglutide versus placebo, was reported for STEP 1 (OR = 2.11 [95% CI, 1.53 to 2.91]), STEP 2 (OR = 1.72 [95% CI, 1.16 to 2.55]), STEP 3 (OR = 1.40 [95% CI, 0.80 to 2.44]), and STEP 4 (OR = 2.72 [95% CI, 1.18 to 6.29]) (Table 28)

The injection can be administered at any time of day, with or without meals, but maintaining a consistent day each week optimizes adherence

Your dose may need to go up, but your price won'tPlexusDx maintains flat monthly pricing across all commitment tiers

Some P.A

Therefore, it appears reasonable to consider selenium supplementation as a beneficial intervention for this group